Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation.
Hyperammonemia after lung transplantation is a rare complication of unknown etiology. Its management is largely supportive and outcomes have been variable. More disconcerting is its immunosuppressive management because the precipitating factors leading to this potentially lethal entity are unknown, but are suspected to be drug-related. We describe the successful management of a lung transplant recipient with severe hyperammonemia.
Moffatt-Bruce
Susan D
SD
Division of Cardiothoracic Surgery, Department of Surgery, The Ohio State University Medical Center, Columbus, OH 43221, USA. susan.moffatt-bruce@osumc.edu
Pesavento
Todd
T
Von Viger
John
J
Nunley
David
D
Pope-Harman
Amy
A
Martin
Stanley
S
Ross
Patrick
P
D000641:Ammonia / Q000097:blood*; D006801:Humans; D022124:Hyperammonemia / Q000209:etiology* / Q000628:therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D007166:Immunosuppressive Agents; D000641:Ammonia